FindTrial
Sign In

Study of transdermal drug patches used for acute pain in major public hospital

An observational study to evaluate the use of transdermal patches for acute pain in surgery wards in a tertiary care centre

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/02/050112
Enrollment
150
Registered
2023-02-27
Start date
Unknown
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R688- Other general symptoms and signs

Interventions

Control Intervention1: observational study: observational study

Sponsors

Seth GSMC and KEM Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: all patient having transdermal patches who are willing to participate will be included

Exclusion criteria

Exclusion criteria: Not willing to give consent Psychiatric disorder

Design outcomes

Primary

MeasureTime frame
Most common transdermal patch, percentage of pain relief, type of painTimepoint: Baseline, 1 month, 6 months—

Secondary

MeasureTime frame
to decrease use of transdermal patches in acute pain for unindicated reasonsTimepoint: 2 years—

Countries

India

Contacts

Public ContactDr Sweta Salgaonkar

Seth GSMC and KEM Hospital, Mumbai

swetavs@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026